TGF-β signaling in the tumor microenvironment promotes T-reg cell infiltration and the activation of cancer-associated fibroblasts, which can accelerate tumor progression and impair anti-tumor immunity (30–32). The gene discussed is TGFB1; the disease is neoplasm.